{"id":"W2791029557","doi":"10.1097/qai.0000000000001649","title":"Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada","year":2018,"lang":"en","type":"letter","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"British Columbia Centre for Disease Control; Public Health Agency; Public Health Agency of Canada","keywords":"Raltegravir; Dolutegravir; Integrase inhibitor; Elvitegravir; Integrase; Medicine; Drug resistance; ANTIRETROVIRAL AGENTS; Virology; Human immunodeficiency virus (HIV); Pharmacology; Antiretroviral therapy; Biology; Viral load; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008296671,0.0004948079,0.0006108138,0.003733896,0.002835101,0.002955676,0.002138342,0.002088225,0.01518595],"category_scores_gemma":[0.006439573,0.0003154222,0.0004107054,0.005258674,0.001053528,0.0009516838,0.0009598155,0.002042223,0.001670058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01262377,"about_ca_system_score_gemma":0.03886718,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8776132,"about_ca_topic_score_gemma":0.9103776,"domain_scores_codex":[0.9984091,0.00005961078,0.0001525254,0.0002278586,0.0008813747,0.0002695858],"domain_scores_gemma":[0.9872034,0.001002005,0.001735588,0.0001161235,0.007282177,0.00266065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0001630826,0.00007485929,0.1198197,0.001697375,0.00007861566,0.001433956,0.0008047979,0.00008054332,0.0004201525,0.0005406758,0.7902995,0.08458667],"study_design_scores_gemma":[0.0001003755,0.0001304409,0.4514629,0.004032458,0.0002973582,0.01121719,0.005003208,0.001126241,0.0005952756,0.0004819287,0.5253017,0.000250909],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1674263,0.3036812,0.001106909,0.3339413,0.08014255,0.0004356771,0.05062195,0.000835538,0.06180852],"genre_scores_gemma":[0.605869,0.1885235,0.001797869,0.1024589,0.04077041,0.0001757056,0.0160372,0.0004587113,0.04390861],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1223868,"threshold_uncertainty_score":0.2462151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0099447566250841,"score_gpt":0.2173568242446781,"score_spread":0.207412067619594,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}